ARTICLE | Clinical News
ReoPro abciximab: Postmarketing study data
April 2, 2012 7:00 AM UTC
The single-blind, international postmarketing INFUSE-AMI trial in 452 patients with ST-segment-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) showed that a...